Related Experiment Video

Updated: Jun 28, 2026

Semi-quantitative Detection of RNA-dependent RNA Polymerase Activity of Human Telomerase Reverse Transcriptase Protein
08:26

Semi-quantitative Detection of RNA-dependent RNA Polymerase Activity of Human Telomerase Reverse Transcriptase Protein

Published on: June 12, 2018

Specific expression of short-interfering RNA driven by human telomerase reverse transcriptase promoter in tumor cells

Xuejing Luan1, Limin Guo, Zuozhen Yang

  • 1Tianjin Life Science Research Center and Basic Medical School, Tianjin Medical University, Tianjin 300070, China.

Acta Biochimica Et Biophysica Sinica
|November 8, 2008
PubMed

Insights

This study introduces a novel tumor-specific RNA interference (RNAi) system. By utilizing the human telomerase promoter, this approach aims to overcome non-specific effects of short-interfering RNA (siRNA) for potential RNAi cancer therapy.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • RNA interference (RNAi) using short-interfering RNA (siRNA) effectively inhibits gene expression in human cells.
  • Non-specific effects of siRNA, including off-target inhibition and immune response activation, limit its therapeutic application.
  • Telomerase is highly active in over 90% of human tumors, making it a promising cancer marker.

Purpose of the Study:

  • To develop a tumor-specific RNA interference (RNAi) system.
  • To target gene silencing specifically in malignant cells.
  • To provide a foundation for advanced RNAi-based cancer therapies.

Main Methods:

  • Utilizing the human telomerase reverse transcriptase promoter to drive RNAi.
  • Designing short-interfering RNA (siRNA) constructs for targeted gene silencing.
  • Evaluating the specificity and efficacy of the developed RNAi system in a tumor context.

Main Results:

  • Demonstrated successful development of a tumor-specific RNAi system.
  • Showcased the potential to overcome limitations of conventional siRNA therapies.
  • Established a novel strategy for targeted gene silencing in malignancies.

Conclusions:

  • The developed tumor-specific RNAi system holds promise for targeted cancer therapy.
  • This approach may mitigate off-target effects associated with standard siRNA.
  • Further research can build upon this system for effective RNAi-based cancer treatments.

More Related Videos

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

Generation of Cancer Cell Clones to Visualize Telomeric Repeat-containing RNA TERRA Expressed from a Single Telomere in Living Cells09:13

Generation of Cancer Cell Clones to Visualize Telomeric Repeat-containing RNA TERRA Expressed from a Single Telomere in Living Cells

Published on: January 17, 2019

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...